Stay updated on Nivolumab and Ipilimumab in Advanced Liver Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and Ipilimumab in Advanced Liver Cancer Clinical Trial page.

Latest updates to the Nivolumab and Ipilimumab in Advanced Liver Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.3.2 replaces v3.3.1 in the page footer; no study data or page functionality were changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check21 days agoChange DetectedRevision: v3.3.1 was added and Revision: v3.2.0 was removed, updating the page's version label in the record history. This is a minor metadata update and does not affect study data or functionality.SummaryDifference0.0%

- Check29 days agoChange DetectedThe site-wide funding/operating-status banner was removed; the study history content and links on the page appear unchanged.SummaryDifference0.3%

- Check43 days agoChange DetectedNo meaningful changes were observed in the Record History page; the new screenshot shows the same content with only cosmetic/layout differences.SummaryDifference0.0%

- Check72 days agoChange DetectedThe page now includes a government-operation status notice and references to visiting NIH/cc.gov and opm.gov, and it increments the revision to v3.2.0, replacing the previous v3.1.0.SummaryDifference8%

- Check79 days agoChange DetectedUpdated the page from Revision: v3.0.2 to Revision: v3.1.0, signaling a new release version.SummaryDifference0.2%

Stay in the know with updates to Nivolumab and Ipilimumab in Advanced Liver Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and Ipilimumab in Advanced Liver Cancer Clinical Trial page.